Sofosbuvir Enrolling by Invitation Phase 3 Trials for Hepatitis C Virus Infection, Response to Therapy of Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03343444Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents